Sparing of previously irradiated skin from erlotinib-induced acneiform rash

Journal of the American Academy of Dermatology

Volumn 58, Issue 1, 2008, Pages 178-179

  Yalçin, Şuayib ^a   Dizdar, Ömer ^a   Yalçin, Başak ^b   Gököz, Özay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEMCITABINE;

ACNE; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DRUG ERUPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT DURATION;

ACNE VULGARIS; ADULT; CARCINOMA, NON-SMALL-CELL LUNG; EXANTHEMA; HUMANS; LUNG NEOPLASMS; MALE; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN;

EID: 37349016556     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.10.988     Document Type: Article

References (5)

1. Cohen M.H., Johnson J.R., Chen Y.F., Sridhara R., and Pazdur R. FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist 10 (2005) 461-466
2. Moore M.J., Goldstein D., Hamm J., Figer A., Hecht J., Gallinger S., et al. Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. American Society of Clinical Oncology 2005 Annual Meeting Proceedings (abstract 1). J Clin Oncol 23 Part I (2005) 1
3. Perez-Soler R., and Saltz L. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?. J Clin Oncol 23 (2005) 5235-5246
4. Busam K.J., Capodieci P., Motzer R., Kiehn T., Phelan D., and Halpern A.C. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 144 (2001) 1169-1176
5. Lawenda B.D., Gagne H.M., Gierga D.P., Niemierko A., Wong W.M., Tarbell N.J., et al. Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys 60 (2004) 879-887